Loading...
XLON
DOCS
Market cap929mUSD
Jul 10, Last price  
71.50GBP
Name

Dr Martens PLC

Chart & Performance

D1W1MN
XLON:DOCS chart
P/E
28.75
P/S
0.89
EPS
0.02
Div Yield, %
3.52%
Shrs. gr., 5y
-0.42%
Rev. gr., 5y
-0.21%
Revenues
765m
-2.88%
163,904,000235,300,000232,400,000290,600,000348,600,000454,400,000672,200,000773,000,000908,300,0001,000,300,000877,100,000787,600,000764,900,000
Net income
24m
+428.89%
-32,000,000200,000-12,000,000-11,300,000-5,700,00017,200,00074,800,00034,700,000181,200,000128,900,00069,200,0004,500,00023,800,000
CFO
126m
-36.07%
5,024,00019,800,00025,800,00034,400,00046,000,00056,000,000121,400,000121,400,000184,400,00077,300,000167,900,000196,300,000125,500,000
Dividend
Aug 27, 20261.7 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Dr. Martens Plc engages in the manufacture and sale of footwear products. The firm offers boots, shoes, sandals, shoe care products, laces, and socks. It operates through the following geographical segments: EMEA, Americas, and APAC. The company was founded by Klaus Maertens in 1945 and is headquartered in London, the United Kingdom.
URL
https://www.drmartensplc.com/
IPO date
Jan 29, 2021
Employees
2,591
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT